Serum miR‐146a level is a potential biomarker in predicting the outcome of diffuse large B‐cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum miR‐146a level is a potential biomarker in predicting the outcome of diffuse large B‐cell lymphoma

Published:2022-12-20 Issue: Volume: Page:
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Huang Xin¹²^ORCID,Gui Ailing²,Zhou Yi¹,Xia Zuguang¹,Liu Wen²,Zuo Ji²,Yang Ling²,Zhang Qunling¹

Affiliation:

1. Department of Lymphoma, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College Fudan University Shanghai China

2. Department of Cellular and Genetic Medicine, School of Basic Medical Sciences Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13911

Reference24 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

3. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

4. Diffuse large B-cell lymphoma: R-CHOP failure—what to do?

5. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP